GlobeNewswire

Channel Medsystems Series C, led by InnovaHealth Partners, LP Reaches $30 Million as the Company Accelerates Commercial Expansion of Cerene®
20/08/2026
Investment supports the continued growth of the Cerene® Cryotherapy platform, enabling greater access for women suffering from heavy menstrual bleeding and dysmenorrhea BERKELEY, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE [...]
A Child's Light Successfully Completes Somatic Movement Pilot Program 'Strong Bodies, Calm Minds' to Support Youth Mental Health
20/08/2026
The Flagship Group Program Integrated Non-Contact Movement and Somatic Therapy to Break Emotional Barriers, Build Self-Regulation, and Help Local Children Heal Downingtown, PA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- A Child' [...]
SK pharmteco to Attend CPHI, Showcasing Multimodal CDMO Capabilities and Global Manufacturing Infrastructure
20/08/2026
Executive leadership and technical experts to highlight end-to-end small molecule and viral vectors solutions SK pharmteco is Official Sponsor of the CPHI Sustainability Summit and the Sustainability Theater RANCHO [...]
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
20/08/2026
TORONTO, Aug. 20, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that its Board of Directors has [...]
Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment
20/08/2026
Polyrizon completes contracting with all five U.S. clinical sites and advances its NASARIX™ study toward enrollment of 120 patients Raanana, Israel, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “ [...]
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
20/08/2026
Innova is backed by leading investors and healthcare groups: Alkhabeer Capital, with more than $2.5 billion AUM; Tamer Group, a pharma manufacturing partner to Astellas and Daiichi Sankyo; and Cigalah Group, whose [...]
Flow Cleanrooms & Supply Expands Availability of DuPont™ Tyvek® IsoClean® and Dupont™ Tyvek® 400 Garments
20/08/2026
GRAND RAPIDS, Mich., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Flow Cleanrooms & Supply today announces the expanded availability of DuPont™ Tyvek ® IsoClean ® and DuPont™ Tyvek ® 400 garments , providing customers with [...]
Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference
20/08/2026
ORANGE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will participate in and attend two upcoming healthcare conferences in New York: Presenting: Baird 2026 [...]
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
20/08/2026
Designation reflects serious unmet need in idiopathic pulmonary fibrosis (IPF), where approved therapies slow but do not halt disease progression Actively enrolling patients in the RENEW Phase 2 trial evaluating LTI-03 [...]
Adagene to Participate in Three Upcoming Investor Conferences
20/08/2026
SAN DIEGO and SUZHOU, China, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (Nasdaq: ADAG) a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based [...]
VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX C001 in urgent surgery
20/08/2026
VarmX enrols first participant in global Phase 3 EquilibriX‑S trial evaluating VMX‑C001 in urgent surgery First participant enrolled:  EquilibriX‑S (NCT07288489), a landmark registrational Phase 3 study of VMX-C001 vs [...]
Evaxion announces business update and second quarter 2026 financial results
20/08/2026
COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business update and [...]
InflaRx Announces Participation in September Investor Conferences
20/08/2026
Jena, Germany, Aug. 20, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate [...]
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines
20/08/2026
Pharmacokinetic and dosimetry findings of Reyobiq from RESPECT-LM single dose study shows broad CSF compartmental distribution and on target drug activity. Update on ongoing multidose leptomeningeal metastases trial [...]
Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
20/08/2026
Hot Line Presentation of Primary Results from ACACIA-HCM to Elaborate on Positive Topline Results in Patients with Non-Obstructive Hypertrophic Cardiomyopathy Company to Host In-Person and Virtual Investor Event to [...]
Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates
20/08/2026
New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing First-Party [...]
Herantis Pharma releases 1H 2026 report today
20/08/2026
Espoo, Finland, August 20, 2026: Herantis Pharma Plc ("Herantis") a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, releases today the Company’s 1H 2026 [...]
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
20/08/2026
Advancing RAD202 Phase 1 trial to next dose level of 180mCi in patients with HER2+ advanced solid tumors Previous diagnostic study of RAD202 in ten HER2-positive breast cancer patients demonstrated clinical proof-of- [...]
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764
20/08/2026
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764 ACI-19764 is an orally available inhibitor of the NLRP3 inflammasome Preliminary data showed ACI-19764 was safe and well tolerated [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum